Evelo Biosciences Inc. (EVLO) OTC MARKETS
$0.04 - (-)
Market Cap: -
As of 04/23/24 12:00 AM EDT. Market open.
Evelo Biosciences Inc. (EVLO)
OTC MARKETS
$0.04
- (-)
Market Cap: -
As of 04/23/24 12:00 AM EDT. Market open.
Add to Portfolio
evelo biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. these new medicines are broadly applicable across many diseases – including ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Base)
$491,817
CEO Compensation (Total)
$4.47M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
111
CEO Compensation (Base)
$491,817
CEO Compensation (Total)
$4.47M
URL
Address
.
PRICE CHART FOR EVELO BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.35
Previous Close
$0.04
Days Range
$0.04 - $0.04
52 week range
- - -
Volume
1,465
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
18,982,837
Open
$0.35
Previous Close
$0.04
Days Range
$0.04 - $0.04
52 week range
- - -
Volume
1,465
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
18,982,837
FINANCIAL STATEMENTS FOR EVELO BIOSCIENCES INC
LOADING...
INSIDER TRANSACTIONS FOR EVELO BIOSCIENCES INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Bodmer Mark | CSO, President of R&D | Nov 08, 2023 | Sale | $0.33 | 3,163 | 1,044 | 25,732 | Nov 08, 2023, 08:32 PM |
McHale Duncan | Chief Medical Officer | Nov 08, 2023 | Sale | $0.33 | 3,103 | 1,024 | 16,984 | Nov 08, 2023, 08:32 PM |
GILL SIMBA | President & CEO | Nov 08, 2023 | Sale | $0.33 | 172 | 57 | 17,758 | Nov 08, 2023, 08:31 PM |
Thorell Marella | Chief Financial Officer | Nov 08, 2023 | Sale | $0.33 | 1,811 | 598 | 22,259 | Nov 08, 2023, 08:31 PM |
Bodmer Mark | CSO, President of R&D | Nov 02, 2023 | Sale | $0.33 | 6,854 | 2,262 | 22,270 | Nov 03, 2023, 04:12 PM |
McHale Duncan | Chief Medical Officer | Nov 02, 2023 | Sale | $0.33 | 6,854 | 2,262 | 13,587 | Nov 03, 2023, 04:11 PM |
Thorell Marella | Chief Financial Officer | Nov 02, 2023 | Sale | $0.33 | 3,999 | 1,320 | 17,570 | Nov 03, 2023, 04:11 PM |
GILL SIMBA | President & CEO | Sep 28, 2023 | Sale | $3.94 | 1,996 | 7,864 | 16,758 | Sep 29, 2023, 04:02 PM |
Bodmer Mark | CSO, President of R&D | Aug 08, 2023 | Sale | $9.51 | 3,128 | 29,747 | 16,624 | Aug 09, 2023, 08:44 PM |
GILL SIMBA | President & CEO | Aug 08, 2023 | Sale | $9.51 | 342 | 3,252 | 3,754 | Aug 09, 2023, 08:43 PM |
McHale Duncan | Chief Medical Officer | Aug 08, 2023 | Sale | $9.51 | 3,434 | 32,657 | 7,941 | Aug 09, 2023, 08:42 PM |
Thorell Marella | Chief Financial Officer | Aug 08, 2023 | Sale | $9.51 | 2,004 | 19,058 | 9,069 | Aug 09, 2023, 08:42 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 3,246,753 | 7,499,999 | 3,931,685 | Jul 13, 2023, 05:15 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 1,082,251 | 2,500,000 | 1,493,241 | Jul 13, 2023, 05:15 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | Jul 11, 2023 | Buy | $2.31 | 1,082,251 | 2,500,000 | 1,461,795 | Jul 13, 2023, 05:15 PM |
Bodmer Mark | CSO, President of R&D | May 23, 2023 | Sale | $0.14 | 22,571 | 3,201 | 262,557 | Jun 12, 2023, 04:01 PM |
McHale Duncan | Chief Medical Officer | May 08, 2023 | Sale | $0.13 | 66,730 | 8,375 | 97,516 | May 10, 2023, 09:32 PM |
Bodmer Mark | CSO, President of R&D | May 08, 2023 | Sale | $0.13 | 68,014 | 8,536 | 285,128 | May 10, 2023, 09:31 PM |
Thorell Marella | Chief Financial Officer | May 08, 2023 | Sale | $0.13 | 38,531 | 4,836 | 91,469 | May 10, 2023, 09:31 PM |
GILL SIMBA | President & CEO | May 08, 2023 | Sale | $0.13 | 3,537 | 444 | 58,512 | May 10, 2023, 09:31 PM |
Plinio Mark D. | Chief Commercial Officer | Jan 31, 2023 | Option Exercise | $0.88 | 1,250 | 1,100 | 3,750 | Feb 02, 2023, 04:10 PM |
CARRIERE STEPHEN J | Principal Accounting Officer | Jan 23, 2023 | Sale | $1.06 | 151 | 160 | 203 | Jan 23, 2023, 05:35 PM |
Plinio Mark D. | Chief Commercial Officer | Jul 29, 2022 | Option Exercise | $1.79 | 1,250 | 2,237 | 2,500 | Oct 14, 2022, 04:24 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 1,369,863 | 2,000,000 | 5,495,324 | Jun 01, 2022, 07:00 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 1,095,890 | 1,599,999 | 1,887,419 | Jun 01, 2022, 07:00 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 4,383,561 | 6,399,999 | 7,590,873 | Jun 01, 2022, 07:00 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 13,698,630 | 20,000,000 | 13,698,630 | Jun 01, 2022, 07:00 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 27, 2022 | Buy | $1.46 | 6,849,315 | 10,000,000 | 8,219,791 | Jun 01, 2022, 07:00 PM |
McHale Duncan | Chief Medical Officer | May 27, 2022 | Buy | $1.46 | 34,246 | 49,999 | 34,246 | May 31, 2022, 04:15 PM |
Darzi Lord Ara | Director | May 27, 2022 | Buy | $1.46 | 342,465 | 499,999 | 342,465 | May 31, 2022, 04:11 PM |
Epstein David R | Director | May 27, 2022 | Buy | $1.46 | 17,123 | 25,000 | 84,080 | May 31, 2022, 04:07 PM |
Plinio Mark D. | Chief Commercial Officer | Jan 31, 2022 | Option Exercise | $4.00 | 1,250 | 5,004 | 1,250 | Feb 01, 2022, 05:31 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | Feb 02, 2021 | Buy | $15.00 | 130,000 | 1,950,000 | 4,125,461 | Feb 04, 2021, 05:56 PM |
Epstein David R | Director | Dec 11, 2020 | Buy | $6.66 | 7,700 | 51,261 | 17,700 | Dec 14, 2020, 05:15 PM |
Liu Xiaoli Jacqueline | Principal Accounting Officer | Dec 01, 2020 | Sale | $5.17 | 3,000 | 15,510 | 0 | Dec 02, 2020, 04:44 PM |
Epstein David R | Director | Aug 31, 2020 | Buy | $4.49 | 5,752 | 25,804 | 10,000 | Sep 01, 2020, 04:13 PM |
Epstein David R | Director | Aug 28, 2020 | Buy | $4.39 | 4,248 | 18,631 | 4,248 | Sep 01, 2020, 04:13 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | Jun 29, 2020 | Buy | $3.75 | 4,666,666 | 17,499,998 | 4,079,032 | Jul 01, 2020, 05:24 PM |
Flagship Ventures Fund IV General Partner LLC | 10% Owner | May 11, 2018 | Buy | $16.00 | 281,250 | 4,500,000 | 18,233,403 | May 15, 2018, 08:43 PM |
Flagship Ventures Fund V General Partner LLC | 10% Owner | May 11, 2018 | Buy | $16.00 | 281,250 | 4,500,000 | 18,233,403 | May 15, 2018, 08:41 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR EVELO BIOSCIENCES INC
LOADING...